Search

Author/Creator Ghannoum, Mahmoud

1. 107. A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules versus Fluconazole and Placebo in the Treatment of Acute Vulvovaginal Candidiasis Episodes in Subjects with Recurrent Vulvovaginal Candidiasis (ultraViolet). (4th December 2021)

Authors:
Martens, Mark G; Maximos, Bassem; Degenhardt, Thorsten; Person, Karen; Curelop, Stacey; Ghannoum, Mahmoud; Brand, Stephen
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S66
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1284. Outcomes by Baseline Pathogens and Susceptibility in the STRIVE Phase 2 Trial of Once-Weekly Rezafungin for Treatment of Candidemia and Invasive Candidiasis Compared with Caspofungin. (31st December 2020)

Authors:
Thompson, George R; Horcajada, Juan P; Locke, Jeffrey B; Viani, Rolando; Pappas, Peter; Ghannoum, Mahmoud; Sandison, Taylor; Soriano, Alex
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S657
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status. (19th June 2018)

Authors:
Presti, Rachel M.; Handley, Scott A.; Droit, Lindsay; Ghannoum, Mahmoud; Jacobson, Mark; Shiboski, Caroline H.; Webster-Cyriaque, Jennifer; Brown, Todd; Yin, Michael T.; Overton, Edgar T.
Journal:
AIDS
Issue:
Volume 32:Number 10(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗